{"schema_version":"secwatch.filing_event.v1","accession":"0000051434-26-000016","form_type":"8-K","ticker":"IP","cik":"0000051434","company_name":"INTERNATIONAL PAPER CO /NEW/","filed_at":"2026-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.438675+00:00","generated_at":"2026-05-16T06:40:37.367676+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"International Paper plans separation into two companies; reports FY2025 loss of $2.84B on $23.6B revenue","bullets":["Plans to create two independent, publicly traded packaging companies in North America and EMEA; separation details to follow.","FY2025 net sales $23.63B; loss from continuing ops $2.84B including $2.47B goodwill impairment and $0.96B accelerated depreciation.","Q4 2025 loss from continuing ops $2.36B (includes $2.47B impairment); adjusted EBITDA $758M.","2026 adjusted EBITDA target $3.5-3.7B; Q1 2026 target $740-760M; excludes future price realization.","Free cash flow FY2025 negative $159M; operating cash flow $1.70B."],"urls":{"canonical":"https://secwatch.observer/filing/0000051434-26-000016","json":"https://secwatch.observer/filing/0000051434-26-000016.json","markdown":"https://secwatch.observer/filing/0000051434-26-000016.md","text":"https://secwatch.observer/filing/0000051434-26-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/51434/000005143426000016/0000051434-26-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/51434/000005143426000016/ip-20260129.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:40:37.367676+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001193125-26-252718","ticker":"QMCO","company_name":"QUANTUM CORP /DE/","filed_at":"2026-06-02T14:41:23+00:00","headline":"Quantum raises $100M equity, converts all convertible notes to equity; Q4 revenue above guidance","event_type":"other_material","sec_items":["1.01","2.02","2.03","3.02","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 2.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252718","json":"https://secwatch.observer/filing/0001193125-26-252718.json","markdown":"https://secwatch.observer/filing/0001193125-26-252718.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/709283/000119312526252718/0001193125-26-252718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/709283/000119312526252718/d35173d8k.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063832","ticker":"USAR","company_name":"USA Rare Earth, Inc.","filed_at":"2026-06-02T13:14:30+00:00","headline":"USA Rare Earth selects South Carolina for $1.2B magnet facility; 490 jobs, 6,400 tpa capacity","event_type":"other_material","sec_items":["1.01","2.03","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063832","json":"https://secwatch.observer/filing/0001213900-26-063832.json","markdown":"https://secwatch.observer/filing/0001213900-26-063832.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1970622/000121390026063832/0001213900-26-063832-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1970622/000121390026063832/ea0293127-8k_usarare.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026761","ticker":"CELC","company_name":"Celcuity Inc.","filed_at":"2026-06-02T12:10:25+00:00","headline":"Gedatolisib doubles PFS vs alpelisib in PIK3CA mutant HR+/HER2- ABC Phase 3 trial","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026761","json":"https://secwatch.observer/filing/0001493152-26-026761.json","markdown":"https://secwatch.observer/filing/0001493152-26-026761.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603454/000149315226026761/0001493152-26-026761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603454/000149315226026761/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-069246","ticker":"SHAK","company_name":"Shake Shack Inc.","filed_at":"2026-06-02T12:06:18+00:00","headline":"Shake Shack cuts Q2 revenue guidance to $415-420M, same-shack sales to 2.5-3.0%","event_type":"other_material","sec_items":["7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069246","json":"https://secwatch.observer/filing/0001104659-26-069246.json","markdown":"https://secwatch.observer/filing/0001104659-26-069246.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620533/000110465926069246/0001104659-26-069246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620533/000110465926069246/tm2616608d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251399","ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2026-06-01T20:05:32+00:00","headline":"IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251399","json":"https://secwatch.observer/filing/0001193125-26-251399.json","markdown":"https://secwatch.observer/filing/0001193125-26-251399.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526251399/0001193125-26-251399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526251399/d138848d8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251394","ticker":"FULC","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2026-06-01T20:05:16+00:00","headline":"Fulcrum Therapeutics discontinues pociredir program in SCD; initiates strategic review","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251394","json":"https://secwatch.observer/filing/0001193125-26-251394.json","markdown":"https://secwatch.observer/filing/0001193125-26-251394.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526251394/0001193125-26-251394-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526251394/fulc-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063486","ticker":"MDAI","company_name":"Spectral AI, Inc.","filed_at":"2026-06-01T20:01:42+00:00","headline":"Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026","event_type":"other_material","sec_items":["5.07","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063486","json":"https://secwatch.observer/filing/0001213900-26-063486.json","markdown":"https://secwatch.observer/filing/0001213900-26-063486.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833498/000121390026063486/0001213900-26-063486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833498/000121390026063486/ea0292962-8k_spectral.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026771","ticker":"BRUN","company_name":"Boost Run Inc.","filed_at":"2026-06-02T12:30:29+00:00","headline":"Boost Run files 8-K referencing investor presentation; exhibit content not included in filing","event_type":"other_material","sec_items":["2.02","7.01","9.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same SEC item: 2.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026771","json":"https://secwatch.observer/filing/0001493152-26-026771.json","markdown":"https://secwatch.observer/filing/0001493152-26-026771.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2090646/000149315226026771/0001493152-26-026771-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2090646/000149315226026771/form8-k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}